# Can Beta-Hydroxy-beta-Methylbutyrate Supplementation Counteract Muscle Catabolism in Critically Ill Patients?

> **NCT03628365** · NA · COMPLETED · sponsor: **Mette M Berger** · enrollment: 37 (actual)

## Conditions studied

- Critical Illness
- Muscle Weakness

## Interventions

- **DIETARY_SUPPLEMENT:** HMB (beta-hydroxy beta-methylbutyrate)

## Key facts

- **NCT ID:** NCT03628365
- **Lead sponsor:** Mette M Berger
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-09-17
- **Primary completion:** 2020-01-06
- **Final completion:** 2020-01-06
- **Target enrollment:** 37 (ACTUAL)
- **Last updated:** 2020-08-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03628365

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03628365, "Can Beta-Hydroxy-beta-Methylbutyrate Supplementation Counteract Muscle Catabolism in Critically Ill Patients?". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03628365. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*